AIV Logo AIV Assistant

 Logo Fortrea Holdings Inc. Common Stock - FTRE 5.28 USD

EPS
-2.44
P/B
1.37
ROE
-13.59
Target Price
24.04 USD

5.280 USD

5.280 USD

Daily: +3.13%
Key Metrics

EPS: -2.44

Book Value: 16.87

Price to Book: 1.37

Debt/Equity: 79.74

% Insiders: 0.281%

Growth

Revenue Growth: -0.06%

Estimates

Forward P/E: 17.44

Forward EPS: 1.31

Target Mean Price: 24.04

 Logo About Fortrea Holdings Inc. Common Stock - (FTRE)

Country: United States

Sector: Health Care

Website: nan

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Exchange Ticker
NMS (United States) FTRE

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion